Practical psychopharmacology in HIV-1 and acquired immunodeficiency syndrome

Psychiatric Clinics of North America

Volumn 25, Issue 1, 2002, Pages 149-175

  Robinson, Michael J ^a,c   Qaqish, Roula B ^b  

^a QUEEN S UNIVERSITY   (Canada)

^b ST LOUIS COLLEGE OF PHARMACY   (United States)

^c KINGSTON GENERAL HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ABACAVIR; AMFEBUTAMONE; AMPRENAVIR; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; ANTIRETROVIRUS AGENT; ANXIOLYTIC AGENT; CITALOPRAM; CLOZAPINE; DELAVIRDINE; DIDANOSINE; EFAVIRENZ; FLUOXETINE; FLUVOXAMINE; HYPNOTIC SEDATIVE AGENT; INDINAVIR; LAMIVUDINE; LOPINAVIR PLUS RITONAVIR; MIRTAZAPINE; MONOAMINE OXIDASE INHIBITOR; NEFAZODONE; NELFINAVIR; NEUROLEPTIC AGENT; NEVIRAPINE; OLANZAPINE; PAROXETINE; PROTEINASE INHIBITOR; REMOXIPRIDE; RITONAVIR; RNA DIRECTED DNA POLYMERASE INHIBITOR; SAQUINAVIR; SERTRALINE; STAVUDINE; TRICYCLIC ANTIDEPRESSANT AGENT; UNINDEXED DRUG; VENLAFAXINE; ZALCITABINE; ZIDOVUDINE; ZIGEN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANXIETY NEUROSIS; CLINICAL TRIAL; COGNITIVE DEFECT; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DELIRIUM; DEPRESSION; DISEASE ASSOCIATION; DRUG EFFECT; DRUG INTERACTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MANIA; MENTAL DISEASE; MOTOR DYSFUNCTION; PRIORITY JOURNAL; PSYCHOSIS; RANDOMIZED CONTROLLED TRIAL; REVIEW; SIDE EFFECT; SYMPTOMATOLOGY;

EID: 0036208281     PISSN: 0193953X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0193-953X(03)00056-X     Document Type: Review

References (89)

1. Practice guideline for the treatment of patients with HIV/AIDS
2. Drug treatment of HIV associated neuropsychiatric syndromes
3. Buspirone in drug users with AIDS or AIDS-related complex
4. Risperidone for AIDS-associated dementia: A case series
5. Pharmacokinetics of gabapentin in subjects with various degrees of renal function
6. AIDS and neuroleptic malignant syndrome
7. Pemoline: An alternative psychostimulant for the management of depressive disorders in cancer patients
8. A double-blind trial of haloperidol, chlorpromazine, and lorazepam in the treatment of delirium in hospitalized AIDS patients
9. Didanosine-induced mania in HIV infection
10. Human immunodeficiency virus-associated dementia
11. Hepatotoxicity with combination of valproic acid, ritonavir, and nevirapine: A case report
12. Secondary mania in patients with HIV infection
13. Major depressive disorder and HIV-1 infection: A review of treatment trials
14. Randomized, placebo-controlled trial of paroxetine versus imipramine in depressed HIV-positive outpatients
15. Antidepressant efficacy in HIV-seropositive outpatients with major depressive disorder: An open trial of nefazodone
16. Mirtazapine for depression in patients with human immunodeficiency virus
17. Lamotrigine for the treatment of bipolar disorder
18. Response of HIV-related depression to psychostimulants: Case reports
19. Psychopharmacological interventions in HIV infections
20. The use of molindone in the treatment of psychotic and delirious patients infected with the human immunodeficiency virus: Case reports
21. Effects of methylphenidate in HIV-related depression: A comparative trial with desipramine
22. Highly active antiretroviral treatment in HIV infection: Benefits for neuropsychological function
23. Adverse neuropsychiatric effects of dopamine antagonist medications: Misdiagnosis in the medical setting
24. Antidepressant treatment of depression in HIV-seropositive women
25. Effect of ritonavir on the pharmacokinetics and pharmacodynamics of alprazolam
26. Nimodipine plus zidovudine versus zidovudine alone in the treatment of HIV-1-associated cognitive deficits
27. Using pharmacokinetics to optimize antiretroviral drug-drug interactions in the treatment of human immunodeficiency virus infection
28. Rational psychopharmacology for patients with HIV infection and AIDS
29. Notes on the use of fluvoxamine as treatment of depression in HIV-1-infected subjects
30. Efficacy of paroxetíne for the treatment of depression in the context of HIV infection
31. Alprazolam-ritonavir interaction: Implications for product labeling
32. Effects of hypogonadism and testosterone administration on depression indices in HIV-infected men
33. The entry of antiviral and antiretroviral drugs into the central nervous system
34. Does valproate pose a threat to human immunodeficiency virus-infected patients?
35. Extrapyramidal symptoms due to dopamineblocking agents in patients with AIDS encephalopathy
36. Carbamazepine-indinavir interaction causes antiretroviral therapy failure
37. Evaluation of memantine for neuroprotection in dementia
38. Possible risks associated with valproate treatment of AIDS-related mania
39. The use of valproic acid in HIV-positive patients
40. Comment: Potential risk of valproic acid therapy in patients who are HIV-positive
41. Inhibition of HIV replication by neuroleptic agents and their potential use in HIV infected patients with AIDS related dementia
42. Pharmacological treatment for bipolar disorder: An update
43. Neuroleptic malignant syndrome associated with use of risperidone, ritonavir, and indinavir: A case report
44. Pilot study with clozapine in patients with HIV-associated psychosis and drug-induced parkinsonism
45. Venlafaxine and indinavir: Results of pharmacokinetic interaction study
46. A report of eight HIV-seropositive patients with major depression responding to fluoxetine
47. AIDS mania
48. The effect of divalproex sodium on viral load: A retrospective review of HIV-positive patients with manic syndromes
49. Treatment of depressive symptoms in human immunodeficiency virus-positive patients
50. Use of stimulants in the medically ill
51. Human immunodeficiency virus-associated dementia
52. Possible induction of mania by buspirone
53. Buspirone-induced mania
54. Pharmacotherapy of HIV dementia
55. Saquinavir interaction with midazolam: Pharmacokinetic considerations when prescribing protease inhibitors for patients with HIV disease
56. Secondary mania in patients with HIV infection: Are antiretrovirals protective?
57. A phase I/II thai of nimodipine for HIV-related neurologic complications
58. HIV neuropathy treated with gabapentin
59. Depression in patients with HIV infection
60. Interactions among drugs for HIV and opportunistic infections
61. Buspirone-induced mania
62. Effects of sertraline on mood and immune status in patients with major depression and HIV illness: An open trial
63. Effect of imipramine on mood and enumerative measures of immune status in depressed patients with HIV illness
64. Effects of fluoxetine on mood and immune status in depressed patients with HIV illness
65. Testosterone therapy for human immunodeficiency virus-positive men with and without hypogonadism
66. Fluoxetine treatment for depression in patients with HIV and AIDS: A randomized, placebo-controlled trial
67. A double-blind, placebo-controlled trial of testosterone therapy for HIV-positive men with hypogonadal symptoms
68. Are newer antidepressants really "better tolerated"?
69. Metabolism of some "second"- and "fourth"- generation antidepressants: Iprindole, viloxazine, bupropion, mianserin, maprotiline, trazodone, nefazodone, and venlafaxine
70. A randomized, double-blind, placebo-controlled trial of deprenyl and thiotic acid in HIV-associated cognitive impairment
71. A prospective analysis of 24 episodes of neuroleptic malignant syndrome
72. Transdermal selegiline in HIV-associated cognitive impairment: Pilot, placebo-controlled study
73. Randomized trial of the platelet-activating factor antagonist lexipafant in HIV-associated cognitive impairment. Neurological AIDS Research Consortium
74. Neuropsychological outcome of zidovudine (AZT) treatment of patients with AIDS and AIDS-related complex
75. Double-blind comparison of fluoxetine and desipramine in the treatment of depressed women with advanced HIV disease: A pilot study
76. Zidovudine treatment of the AIDS dementia complex: Results of a placebo- controlled trial
77. A placebo-controlled trial of lamotrigine for painful HIV-associated neuropathy
78. Treatment of HIV-related psychotic disorders with risperidone: A series of 21 cases
79. HIV-associated dementia: New insights into disease pathogenesis and therapeutic interventions
80. Nonenteral routes of administration for psychiatric medications. A literature review
81. Buspirone-induced psychosis in a human immunodeficiency virus-infected man
82. Significant interactions with new antiretrovirals and psychotropic drugs
83. Effects of dextroamphetamine on depression and fatigue in men with HIV: A double-blind, placebo-controlled trial
84. Neuropsychiatry of HIV-associated dementia
85. Methylphenidate as a treatment for depression in acquired immunodeficiency syndrome: An n-of- 1 trial
86. Zidovudine-related mania
87. Treatment of major depression in HIV-seropositive men